PEPFAR News and Research RSS Feed - PEPFAR News and Research

Study suggests strong treatment programs can help make headway against AIDS epidemic

Study suggests strong treatment programs can help make headway against AIDS epidemic

Botswana appears to have achieved very high rates of HIV diagnosis, treatment, and viral suppression--much better than most Western nations, including the United States--according to a new study from Harvard T.H. Chan School of Public Health and colleagues in Botswana. [More]
Dapivirine ring can help prevent HIV-1 infection in women

Dapivirine ring can help prevent HIV-1 infection in women

In an important scientific achievement for women's health, two large Phase III clinical trials -- The Ring Study and ASPIRE -- have shown that a monthly vaginal ring containing the antiretroviral drug (ARV) dapivirine can safely help prevent HIV-1 infection in women. [More]
New US bipartisan study advocates promoting global health to advance wide range of American interests

New US bipartisan study advocates promoting global health to advance wide range of American interests

A new US bipartisan study advocates promoting global health to both "do the right thing" and advance wide-ranging foreign policy interests. [More]

EGPAF, EJAF launch new project to expand HIV treatment, prevention efforts for adolescents in Africa

The Elizabeth Glaser Pediatric AIDS Foundation and the Elton John AIDS Foundation today launched a new project to expand HIV treatment and prevention efforts for adolescents in urban settings in Kenya and Zambia. [More]
UNITAID report examines new technologies, key market challenges to improved access to better TB diagnostics

UNITAID report examines new technologies, key market challenges to improved access to better TB diagnostics

More than 50 companies are actively developing new products to diagnose tuberculosis (TB), a disease that killed 1.5 million people in 2013, but many countries still rely on older sputum-based methods, according to a report published by UNITAID. [More]
Generex agrees to acquire 51% equity interest in Hema Diagnostic Systems

Generex agrees to acquire 51% equity interest in Hema Diagnostic Systems

Generex Biotechnology Corporation today announced that it has entered into a non-binding Letter of Intent (LOI) with Hema Diagnostic Systems, LLC (HDS), a Florida company that designs and manufactures proprietary infectious disease detection technologies. [More]
HIV cure research may shift from single-therapy development model to combination therapy trials

HIV cure research may shift from single-therapy development model to combination therapy trials

The next five years of HIV research should shift gears from the classic single-therapy development model to moving directly from in vitro studies to combination therapy trials, authors argue in a new paper published online today. [More]
Panelists to discuss current state of Ebola epidemic at O’Neill Institute Colloquium

Panelists to discuss current state of Ebola epidemic at O’Neill Institute Colloquium

The O'Neill Institute for National and Global Health Law fall colloquium series continues Wednesday, Sept. 16 with a focus on Ebola. [More]
Multiple HIV-1 variants at the beginning of infection impact viral load setpoints

Multiple HIV-1 variants at the beginning of infection impact viral load setpoints

HIV-1 infection with multiple founder variants points to poorer clinical outcomes than infection with a single variant, according to a paper published today in the journal Nature Medicine. [More]
CONRAD announces new funding agreement to increase HIV prevention products for high risk women in Africa

CONRAD announces new funding agreement to increase HIV prevention products for high risk women in Africa

CONRAD is pleased to announce a new funding agreement, in collaboration with the U.S. President's Emergency Plan for AIDS Relief and the U.S. Agency for International Development, in support of a human centered design (HCD) strategy to increase demand, use and adherence of HIV prevention products for high risk women in Africa. [More]
New report highlights key success in global response to preventing AIDS in women, children

New report highlights key success in global response to preventing AIDS in women, children

The Elizabeth Glaser Pediatric AIDS Foundation applauds today's announcement from the Joint United Nations Programme on HIV/AIDS that the goal of providing 15 million people with lifesaving antiretroviral therapy (ART) by 2015 has been met nine months ahead of schedule. [More]
WHO prequalifies new male circumcision device to prevent HIV

WHO prequalifies new male circumcision device to prevent HIV

The ShangRing, a novel medical device for voluntary medical male circumcision, has received prequalification from the World Health Organization (WHO) for use. [More]

Tentative FDA approval of lopinavir/ritonavir oral pellet formulation closes treatment gap for children with HIV

Infants and young children living with HIV will finally have access to an improved formulation of an antiretroviral (ARV) treatment, following the U.S. Food and Drug Administration's tentative approval last week of lopinavir/ritonavir (LPV/r) oral pellets developed by the Indian generic company Cipla. [More]
Sexual violence against children significantly higher in low- and middle-income countries

Sexual violence against children significantly higher in low- and middle-income countries

Sexual violence against children is a significant problem in many low- and middle-income countries. At least 25 percent of females and 10 percent of males experienced some form of childhood sexual violence in the majority of seven countries studied, according to findings from the Violence Against Children Surveys (VACS) released today in the Morbidity and Mortality Weekly Report (MMWR) by the Centers for Disease Control and Prevention. [More]
Ebola survivors face long-term adverse health effects: Study

Ebola survivors face long-term adverse health effects: Study

Ebola survivors experienced negative health effects that persisted more than two years after the 2007-2008 Bundibugyo ebolavirus (BDBV) outbreak in Uganda that claimed 39 lives. These findings are detailed in a paper published online today in Lancet ID. [More]

MPP, MSD sign licensing agreement for paediatric formulations of raltegravir

The Medicines Patent Pool announced a licence today with MSD, known as Merck in the United States and Canada, for paediatric formulations of raltegravir, a key medicine approved for children living with HIV four weeks of age and older. [More]
UNICEF and UNAIDS go ‘All In’ to end the AIDS epidemic among adolescents

UNICEF and UNAIDS go ‘All In’ to end the AIDS epidemic among adolescents

AIDS has become the second leading cause of death among adolescents globally. Just one in four children and adolescents under the age of 15 have access to life-saving antiretroviral treatment. Deaths are declining in all age groups, except among 10–19 year olds. [More]
Cannabis Science, CFA partner to improve health-related education infrastructure in Africa

Cannabis Science, CFA partner to improve health-related education infrastructure in Africa

Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is pleased to announce its President & CEO, Mr. Raymond C. Dabney, along with CBIS's Senior Scientific Advisor, Dr. Roscoe M. Moore, Jr., have initiated a partnership between CBIS and the Constituency for Africa to help improve the healthcare and health-related education infrastructure in Africa. [More]
Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration for its New Drug Applications (NDAs) for two dosages of abacavir/lamivudine tablets for oral suspension for the treatment of HIV-1 infection in pediatric patients. [More]
Medical education in sub-Saharan Africa is being revitalized through U.S. funded effort

Medical education in sub-Saharan Africa is being revitalized through U.S. funded effort

Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies. [More]
Advertisement
Advertisement